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SUMMARY
The aim of this study was to determine the potential association between housing type and
multiple drug resistance (MDR) in Escherichia coli and Enterococcus faecalis isolates
recovered from 283 laying-hen ﬂocks. In each ﬂock, a cloacal swab from four hens was
collected and produced 1102 E. coli and 792 E. faecalis isolates. Broth microdilution was used
to test susceptibility to antimicrobials. Country and housing type interacted diﬀerently with
the MDR levels of both species. In the E. coli model, housing in a raised-ﬂoor system was
associated with an increased risk of MDR compared to the conventional battery system
[odds ratio (OR) 2.12, 95% conﬁdence interval (CI) 1.13–3.97)]. In the E. faecalis model the
MDR levels were lower in free-range systems than in conventional battery cages (OR 0.51,
95% CI 0.27–0.94). In Belgium, ceftiofur-resistant E. coli isolates were more numerous than
in the other countries.
Key words: Antimicrobial resistance in agricultural settings, Enterococcus, Escherichia coli,
veterinary epidemiology.
INTRODUCTION
The therapeutic, prophylactic and metaphylactic use
of antimicrobials is common practice in modern food-
animal husbandry [1–3]. Concerns have grown that
this widespread use of antimicrobial drugs may lead to
an increase in antimicrobial resistance in numerous
bacteria potentially aﬀecting public health [4, 5].
Standardized and continuous surveillance pro-
grammes are necessary to monitor the occurrence and
persistence of antimicrobial resistance in food animals
[3, 6, 7]. Indicator bacteria are generally used to
monitor antimicrobial resistance since they can be
commonly found in healthy animals. In addition, these
bacteria acquire antimicrobial resistance faster than
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other commonly found bacteria [6, 8, 9]. Commensal
Escherichia coli and Enterococcus faecalis are inter-
nationally used as respective Gram-negative and
Gram-positive indicator bacteria for monitoring
antimicrobial resistance because of their common
presence in the animal intestinal tract [10–12]. Sur-
veillance of antimicrobial resistance is performed
in several countries [2], yet these surveillance pro-
grammes have generally been focused on cattle,
pig and broiler production. Programmes in laying
hens are still scarce. Therefore, there is a need to
monitor antimicrobial resistance development in lay-
ing hens [3].
According to the Council Directive 1999/74/EC,
from January 2012 onwards conventional battery
cages will be forbidden in the European Union (EU)
[13]. Only enriched cages and non-cage housing
systems will be allowed. Non-cage housing systems
consist of an indoor area that may or may not be
combined with covered (‘wintergarden’) or un-
covered (‘free-range’) outdoor facilities [14, 15]. The
non-cage systems can be categorized into two groups:
single level systems with a ground ﬂoor area which is
fully or partially covered with litter and aviaries,
consisting of a ground ﬂoor area plus one or more
platforms [14, 15]. Free-range organic ﬂocks have the
same structure as a free-range system but there are
some additional requirements concerning maximum
ﬂock size, beak trimming and the origin of the feed.
Moreover, the application of antimicrobials in these
organic ﬂocks is strictly restricted to therapeutic
usage. Presently it is not clear whether the diﬀerent
housing and management systems for laying hens will
inﬂuence the occurrence of antimicrobial resistance.
Recent reports indicate that both in poultry and other
animal species the move from conventional indoor
production towards free-range and organic pro-
duction exerts a beneﬁcial eﬀect on the levels of anti-
microbial resistance in zoonotic and indicator
bacteria [16–19]. On the other hand it has been shown
that this move to non-cage housing systems resulted
in an increased incidence of bacterial diseases [20, 21],
which could potentially lead to increased anti-
microbial usage. However, epidemiological data on
the prevalence of antimicrobial resistance in the
above-mentioned indicator bacteria in laying hens in
diﬀerent housing systems is still limited.
The aim of this paper was to investigate the preva-
lence of antimicrobial resistance in E. coli and
E. faecalis isolates recovered from 283 laying ﬂocks in
four European countries and to evaluate the potential
association between housing systems and observed
multi-drug resistance.
MATERIAL AND METHODS
Farm selection
Flocks were selected from a registry list of laying-hen
farms provided by the oﬃcial identiﬁcation and
registration authorities of the participating countries
(Belgium, Germany, Italy, Switzerland). The farm
size (>1000 laying hens) and the housing type were
the only two selection criteria. The distribution of
sampled farms aimed for was 20% conventional bat-
tery cage systems and 80% non-cage (alternative)
housing systems. Within the group of alternative
housing systems an equal number of aviaries, raised-
ﬂoor, free-range and organic farms was targeted. The
farmers were contacted by telephone and the purpose
of the study was explained. The planned date of de-
population was noted to make sure that the farm
could be sampled in the month prior to depopulation.
Sampling of the laying-hen farms
Four hens in the sampled ﬂock were evenly selected
throughout the house and from each hen one cloacal
swab was taken by inserting a sterile cotton-tipped
swab about 5 cm into the cloaca. The swabs were di-
rectly placed in individual tubes containing Ames
medium.
A questionnaire was completed during an on-farm
interview at the same time that collection of samples
took place. The questionnaire consisted of 92 ques-
tions, with 31 open questions and 61 closed questions.
Prior to the study, the questionnaire was tested on
two Belgian laying-hen farms, one with conventional
battery cages and one with a free-range production
system in order to check whether the questions were
relevant to the aim of this study. The questions were
related to general farm and ﬂock characteristics
such as ﬂock size, breed, age of hens and biosecurity
measures. Special attention was paid to the housing
system of the sampled ﬂock and the antimicrobial
treatments the hens had received during the current
production cycle. The same questionnaire was used in
all participating countries ; a translation from English
to Dutch, German and Italian was performed during
a meeting with all participating countries. For each of
the participating countries one person was designated
to collect the samples and conduct the interview with
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the farmer. Questionnaires can be obtained from
corresponding author upon request.
Bacteriological examination of the samples
E. coli
For the isolation of E. coli the swabs were plated onto
MacConkey plates (Oxoid1, France) and incubated
aerobically for 24 h at 37 xC. From each primary
plate, one colony was selected and plated again onto a
MacConkey agar plate. Suspected colonies were con-
ﬁrmed as E. coli by positive glucose/lactose fermen-
tation, gas production and absence of H2S production
on Kligler iron agar (Oxoid) and absence of aesculin
hydrolysis (bile aesculin agar; Oxoid). In Switzerland,
the following equivalent method was used: the cloacal
swabs were plated onto MacConkey agar (Oxoid) and
incubated for 24 h at 37 xC under aerobic conditions.
Strains which were lactose-positive were subcultured
on Brolacin agar (Merck1, Germany) and incubated
for 24 h at 37 xC under aerobic conditions. Conﬁr-
mation of the strains as E. coli was performed using
RapiD 20 E (bioMe´rieux, France).
E. faecalis
For the isolation of Enterococcus the swab was plated
on Slanetz & Bartley agar (Oxoid). After incubation
for 48 h at 42¡1 xC, one suspected E. faecalis colony
per sampled animal was puriﬁed and veriﬁed by using
Rapid ID 32 STREP strips (bioMe´rieux). In
Switzerland, E. faecalis was isolated from the cloacal
swabs on Enterococcosel agar (Becton, Dickinson
and Company, USA) and incubated for 48 h at 37 xC
under aerobic conditions. On Columbia 5% sheep
blood agar (Oxoid) strains were subcultured and
incubated for 24 h at 37 xC under anaerobic con-
ditions. Conﬁrmation of the strains as E. faecalis was
performed using Rapid ID 32 STREP strips (bio
Me´rieux).
Antimicrobial susceptibility testing
For both indicator bacteria, susceptibility was tested
by means of broth microdilution using custom made
Sensititre1 plates (Trek Diagnostics Systems Ltd,
UK). The antimicrobials tested and their ranges are
listed in Tables 1 and 2 for E. coli and E. faecalis,
respectively. The results were read visually after 24 h
incubation at 37 xC and the minimum inhibitory
concentration (MIC) was deﬁned as the lowest
concentration of the antimicrobial that completely
inhibited visible growth. E. coli ATCC 25922 and
E. faecalis ATCC 29212 were used for quality con-
trol. The European Committee on Antimicrobial
Table 1. Minimum inhibitory concentration (MIC) distribution (%) for 1102 Escherichia coli isolates
(vertical black line indicates cut-oﬀ value)
Distribution (%) of MICs (µg/ml) 
Compound 0·015 0·03 0·06 0·12 0·25 0·5 1 2 4 8 16 32 64 128 256 512 1024 2048
Total % 
resistance 
Ciprofloxacin 89·6 0·5 1·3 5·6 0·0
Cefpodoxime 9·5 56·1 4·4
Ceftiofur 
1·1
26·5
94·6 0·4
Ampicillin 43·2
Gentamicin 
Amoxi/clav. acid 
Chloramphenicol 
Florfenicol 
Neomycin 
Tetracycline 
Colistin 
Streptomycin 
Apramycin 
Cefalothin 
Trimethoprim 
Nalidixic acid 
Spectinomycin 
1·7
3·1
0·8
5·2
94·5 0·9
55·5
25·3
42·6
3·4
0·2
0·3
0·4
32·0
3·0
20·3
2·0
3·8
90·6
73·8 2·9
0·0
66·9
83·4
24·6
90·2
87·4
3·8
3·6
0·3
22·3
67·3
49·3
0·5
0·5
0·9
20·5
13·3
50·1
0·5
1·5
0·0
0·7
1·1
4·3
4·0
0·4
0·0
0·0
3·4
1·9
18·1
0
0·4
68·8
15·8
0·6
0·7
0·4
0·3
5·1
22·8
1·8
1·4
7·1
8·9
0·4
22·5 1·5 1·3
Sulfamethoxazole 
0·7
0·0
6·9
10·3
5·9
81·1 0·8 0·8 0·2 17·0
10·4 
4·7 
4·6 
15·8 
2·5 
1·8 
1·1 
0·3 
5·5 
22·8 
0·9 
8·7 
1·4 
0·1 
9·4 
10·7 
2·8 
17·2 
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Susceptibility Testing (EUCAST) epidemiological
breakpoints for MIC determination were used. When
these EUCAST breakpoints were not available
(which was the case for apramycin, sulfamethoxazole
and kanamycin), the breakpoints mentioned in the
reports of the Danish Integrated Antimicrobial
Resistance Monitoring and Research Programme
were used [22].
Statistical data analysis
An isolate was deﬁned as multiple drug-resistant
(MDR) if it exhibited resistance to two or more anti-
microbials. For both the E. coli and E. faecalis
models, MDR was used as an outcome variable in
statistical analysis. For E. coli, ceftiofur resistance
was also used as an outcome variable. Three separate
statistical models were developed to test these out-
come variables. The questionnaire responses were
transformed to binary or categorical variables.
Pearson’s x2 test was used to determine potentially
signiﬁcant diﬀerences between categorical explorative
variables (P<0.05), and those factors that were sig-
niﬁcant in this univariate analysis were further tested
in the multivariate models. The predictive categorical
factors, consisting of country, housing type, presence
of other farm animals (e.g. pigs, cattle, sheep) on
farm, the presence of hens in the ﬂock originating
from diﬀerent rearing sites and antimicrobial
treatment of the ﬂock were tested for inclusion in the
models. A stepwise forward selection process was
used for the variable selection in a population average
logistic regression model with a P value f0.2 for en-
try, and with a P value f0.10 for retention in the
model. This model did not control for clustering of
isolates within farms but was used for preliminary
testing of signiﬁcant predictive factors. The factors
that were signiﬁcant in this model were introduced
into a model using generalized estimating equations
(GEE) to control for clustering of samples within a
farm using an independent correlation matrix. Inter-
action eﬀects were tested for variables retained in the
ﬁnal GEE model. Odds ratios and 95% conﬁdence
intervals were calculated for the parameters that
were retained in the GEE model and only factors with
a P value f0.05 were retained in the ﬁnal GEE
model. The statistical software package SAS (SAS for
Windows, version 9.1, SAS Institute Inc., USA) was
used for data analysis.
Antimicrobial resistance patterns were described
using cluster analysis. Binary cluster analysis was
performed using the Jaccard matching coeﬃcient and
the centroid method to obtain discrete clusters with
no intra-cluster variability. Due to the large number
of antimicrobial resistance clusters, the descriptive
and stratiﬁed analysis was limited to the 15 most
common resistance patterns describing more than
80% of the isolate dataset.
Table 2. Minimum inhibitory concentration (MIC) distribution (%) for 792 Enterococcus faecalis isolates
(vertical black line indicates cut-oﬀ value)
Distribution (%) of MICs (µg/ml) 
Compound 
Total % 
resistance 
Daptomycin 
Ciprofloxacin 
Erythromycin 
Tetracycline 
Linezolid 
Chloramphenicol 
Vancomycin 
Ampicillin 
Avilamycin 
Salinomycin 
Florfenicol 
Gentamicin 
Kanamycin 
Streptomycin 
Tigecycline 0·1 0·1 25·8 2·1 4·1 21·845·4
1·5 0·4 3·2 42·8 0·3
7·7 20·5 59·8
19·7 19·5 1·6
30·4 1·5
18·2
2·6 0·3
0·1
0 0
1·1
0·015 0·03 0·06 0·12 0·25 0·5 1 2 4 8 16 32 64 128 256 512 1024 2048
0·2
42·6
7·3
19·6
0·4
79·2
2·1
96·4
93·5
94·4
98·6 0·1
7·3
4·6
6·3
0·6
2·2
29·0
3·1
5·2
3·8
1·2
98·0
0·8
0·1
2·6
0·1
0·4
65·8
0·2
0·7
0·6
0·1
1·6 0·1
31·3
67·0
0·3
0·1
0·6
0·2
97·7 0·4 0·1 0
77·1 4·3 1·2 0·8
74·0 1·6 0·7 0·8
1·8
16·4
22·7
26·1 
1·1 
0·1 
35·5 
68·6 
0·4 
0·3 
0·4 
1·3 
1·1 
0·2 
0·3 
1·8 
16·4 
23·5 
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RESULTS
In total, 1102 E. coli isolates and 792 E. faecalis
isolates were collected from 283 laying-hen ﬂocks
(69 Belgian, 85 German, 30 Italian and 99 Swiss
ﬂocks). The participation rate was more than 90% in
Belgium, Italy and Switzerland and 70% in Germany.
A detailed description of the number of isolates per
housing type and per country is presented in Table 3.
The median ﬂock size of the sampled ﬂocks was 7612
laying hens (range 1000–84 000 hens). The ﬂock size in
conventional battery cage houses was signiﬁcantly
higher than the ﬂock size in non-cage systems.
Twenty-four of the 283 sampled ﬂocks were treated
with antimicrobials during the current production
cycle according to the declaration of the farmers.
The number of treated ﬂocks diﬀered signiﬁcantly
between countries (P<0.05) but not between housing
types. In Italy none of the sampled ﬂocks were
treated with antimicrobials, for Belgium this was 3/69
sampled ﬂocks, for Switzerland 5/99 ﬂocks and for
Germany 16/85 sampled ﬂocks. Colistin was the most
frequent treatment (16 ﬂocks), followed by amoxicillin
(ﬁve ﬂocks), neomycin (two ﬂocks) and enroﬂoxacin
(one ﬂock). There was a signiﬁcant diﬀerence between
countries in the number of laying-hen farms where
other production animals were also kept (P<0.05). In
Italy, only 16.7% of the sampled laying-hen farms
managed other animal production on the same site,
whereas in Germany, Belgium and Switzerland this
was 38.5%, 43.8% and 75.5%, respectively.
The distribution of the MICs (in %) of each anti-
microbial is described in Table 1 for E. coli and in
Table 2 for E. faecalis.
MDR in E. coli
The majority of the isolates (55.0%) were susceptible
to all 18 antimicrobials, 16.9% were resistant to one
antimicrobial and the remaining 28.1% were multi-
resistant. The 15 most common resistance phenotypes
of antimicrobial resistance clusters are described in
Table 4. The housing of hens in raised-ﬂoor systems,
compared to conventional battery cages (P=0.02)
and country (P=0.03) turned out to be risk factors
for higher levels of MDR in the ﬁnal GEE logistic
regression model (Table 5). Other factors such as
other animal production on the farm, the presence
of hens originating from diﬀerent rearing farms in
the sampled ﬂock and antimicrobial treatment of the
ﬂock were not retained in the ﬁnal model. When
looking at factors aﬀecting ceftiofur resistance inT
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Table 4. The 15 most common antimicrobial resistance clusters in Escherichia coli isolated from European laying hens
AR
cluster*
No. of
isolates % AR freq# AMC AMP APR CEF CEP CHL CIP COL FLO GEN NAL NEO SPT STR SUL TET TRI XNL
1 606 55.0 0
2 58 5.3 1 R
3 47 4.3 1 R
4 30 2.7 2 R R
5 26 2.4 1 R
6 25 2.3 1 R
7 23 2.1 3 R R R
8 16 1.5 3 R R R
9 15 1.4 2 R R
10 14 1.3 3 R R R
11 9 0.8 3 R R R
12 9 0.8 6 R R R R R R
13 8 0.7 1 R
14 7 0.6 6 R R R R R R
15 7 0.6 9 R R R R R R R R R
Sum$ 900 81.8
AMC, Amoxicillin/clavulanic acid ; AMP, ampicillin ; APR, apramycin ; CEF, cefpodoxime; CEP, cefalothin ; CHL, chloramphenicol ; CIP, ciproﬂoxacin ; COL, colistin ;
FLO, ﬂorfenicol ; GEN, gentamicin ; NAL, nalidixic acid; NEO, neomycin ; SPT, spectinomycin ; STR, streptomycin ; SUL, sulfamethoxzole ; TET, tetracycline ; TRI,
trimethoprim; XNL, ceftiofur.
* AR cluster=antimicrobial resistance cluster describing the pattern of resistance of the isolates.
# AR freq=antimicrobial resistance frequency : the number of antimicrobials to which the E. coli were classiﬁed as resistant (R).
$ The number and percentage of isolates described in this table represent 81.8% of the 1102 total isolates included in this study.
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E. coli, Belgium was more likely to have ceftiofur-
resistant isolates than the other three countries.
Ceftiofur resistance varied from 0.0% (Switzerland),
>2.5% and 4.5% (Italy and Germany, respectively),
to 12.1% in Belgium. No signiﬁcant potential associ-
ation between the other tested risk factors and
ceftiofur resistance was observed.
MDR in E. faecalis
The majority of E. faecalis isolates were multi-
resistant (51.1%), 34.5% were resistant to one
antimicrobial and only 14.4% of all isolates were
pan-susceptible. The 15 most common resistance
phenotypes of antimicrobial resistance clusters are
described in Table 6. The results of the GEE logistic
regression model, showing factors associated with
MDR in E. faecalis are presented in Table 7. The
isolates from laying hens housed in free-range systems
were more likely to have lower levels of MDR
(P=0.03) compared to conventional battery cage
systems. Isolates from Belgian hens had lower levels
of resistance than hens in Germany and Italy. Similar
to the observations in E. coli, other factors such as
other animal production on the farm, antimicrobial
treatment of the ﬂock and the presence of hens
originating from diﬀerent rearing plants in the ﬂock
did not signiﬁcantly interact with the levels of MDR.
DISCUSSION
The levels of MDR in E. faecalis were lower in free-
range laying hens than in the conventional battery
cage system, whereas increased levels of MDR were
seen in E. coli in raised-ﬂoor hens. This is in contrast
to the studies of Schwaiger et al. [17, 18] who found
signiﬁcantly lower levels of antimicrobial resistance in
E. coli and faecal enterococci in free-range organic
laying hens compared to laying hens housed in con-
ventional battery cages. There are several possible
explanations for the ambiguous association between
the non-cage housing types and the level of MDR.
A ﬁrst important factor is exposure to antimicrobials.
In the current study, apart from the free-range or-
ganic ﬂocks, the reported antimicrobial use in laying
hens in the non-cage systems was not signiﬁcantly
lower than in conventional battery cages. The higher
incidence of bacterial diseases in laying hens housed
in non-cage systems as described in several studies
[20, 21] may have resulted in a more frequent use of
antimicrobials. If this were the case, it raises the
question whether, besides the advantages at the an-
imal-welfare level, there will be any adverse conse-
quences for public health on the level of spread and
persistence of antimicrobial resistance in laying hens
in the future. Second, in non-cage systems the chance
of oro-faecal transmission of bacteria is much higher
than in conventional battery cages, both between hens
and between the animals and the environment. This
could also be of importance since, apart from anti-
microbial usage, other factors such as localization and
size of the microbial population [23], and immunity
and contact intensity of the host [24] play a role in
antimicrobial resistance development. Finally, the
fact that many of the sampled farms with non-cage
Table 5. Results of the GEE logistic regression analysis for the identiﬁcation
of risk factors for the presence of multiple drug resistance in Escherichia
coli from European laying hens
Categorical variable
No. of
isolates
Multivariable analysis
OR 95% CI P value
Type of housing
Conventional battery (ref.) 217 — — —
Aviary 142 0.87 0.90–2.26 0.77
Raised-ﬂoor 284 2.12 1.13–3.97 0.02
Free-range 309 0.84 0.42–1.68 0.62
Free-range organic 150 1.02 0.45–2.33 0.96
Country
Belgium (ref.) 256 — — —
Germany 356 0.54 0.31–0.93 0.03
Italy 119 0.73 0.38–1.42 0.36
Switzerland 371 0.86 0.48–1.60 0.67
OR, Odds ratio ; CI, conﬁdence interval.
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production systems made the change to the new pro-
duction systems only a few years before the onset of
the study and that these new production systems are
often located in the same house where previously the
battery cages were present, might also explain the
observed results. It has been described that the de-
crease in antimicrobial resistance following changes in
the production system or in antimicrobial usage
Table 6. The 15 most common antimicrobial resistance clusters in Enterococcus faecalis isolated from
European laying hens
AR
cluster*
No. of
isolates %
AR
freq# AMP AVI CHL CIP DAP ERY FLO GEN KAN LIN SAL STR TET TIG VAN
1 138 15.1 1 R
2 116 14.4 0
3 89 11.1 1 R
4 70 8.7 2 R R
5 48 6.0 4 R R R R
6 42 5.2 5 R R R R R
7 41 5.1 2 R R
8 28 3.5 2 R R
9 23 2.9 4 R R R R
10 23 2.9 3 R R R
11 13 2.1 4 R R R R
12 13 1.6 3 R R R
13 7 0.9 3 R R R
14 7 0.9 2 R R
15 6 0.8 4 R R R R
Sum$ 664 81.2
AMP, ampicillin ; AVI, avilamycin ; CHL, chloramphenicol ; CIP, ciproﬂoxacin ; DAP, daptomycin ; ERY, erythromycin ;
FLO, ﬂorfenicol ; GEN, gentamicin ; KAN, kanamycin ; LIN, linezolid ; SAL, salinomycin ; STR, streptomycin ; TET,
tetracycline ; TIG, tigecyclin ; VAN, vancomycin.
* AR cluster=antimicrobial resistance cluster describing the pattern of resistance of the isolates.
# AR freq=antimicrobial resistance frequency : the number of antimicrobials to which the E. faecalis were classiﬁed as
resistant (R).
$ The number and percentage of isolates described in this table represent 81.2% of the 803 total isolates included in this
study.
Table 7. Results of the GEE logistic regression analysis for the
identiﬁcation of risk factors for the presence of multiple drug resistance in
Enterococcus faecalis from European laying hens
Categorical variable
No. of
isolates
Multivariable analysis
OR 95% CI P value
Type of housing
Conventional battery (ref.) 211 — — —
Aviary 50 1.13 0.39–3.28 0.83
Raised-ﬂoor 207 0.95 0.52–1.72 0.85
Free-range 214 0.51 0.27–0.94 0.03
Free-range organic 121 0.57 0.28–1.18 0.13
Country
Belgium (ref.) 236 — — —
Germany 323 2.67 1.57–4.55 <0.01
Italy 95 13.07 5.69–30.00 <0.01
Switzerland 149 1.86 0.91–3.79 0.09
OR, Odds ratio ; CI, conﬁdence interval.
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policy in food-producing animals is very slow and
that resistance against certain antimicrobials can
still be detected long after direct selection pressure by
antimicrobial usage has ended [25, 26].
The diﬀerence in eﬀect of the housing system on
MDR in E. coli and E. faecalis might be the result of
diﬀerent biological characteristics of both bacterial
species. E. coli is typically an inhabitant of the intes-
tinal tract and is to a considerable extent present in the
hens’ faeces. The animals have frequent oro-faecal
contact in non-cage indoor production systems, re-
sulting in an intense exchange of E. coli between hens.
This high-contact intensity could cause the higher
levels of MDR in laying hens in raised-ﬂoor systems.
Since enterococci are widely distributed in the soil
and the environment [6], access to a pasture may
exert some kind of diluting eﬀect on the intestinal
enterococcal population, leading to lower levels of
MDR in free-range laying hens. However, although
these diﬀerences between the housing types are stat-
istically signiﬁcant, it is not yet clear whether they
have some biological relevance and therefore further
study is necessary to conﬁrm and clarify these ﬁnd-
ings.
Although diﬀerences in methodology of sampling
and analysis between diﬀerent studies have to be
taken into account, the results of our study illustrate
that, in general, the levels of antimicrobial resistance
in indicator bacteria in laying hens are relatively
low compared to broilers, pigs and – to a lesser
extent – cattle [12, 27, 28]. This is in accord with pre-
vious studies in laying hens [17, 18, 29]. The overall
limited antimicrobial usage in egg-producing laying
hens, as shown in the results, could play a role in this
observation since it is generally accepted that the use
of antimicrobials is one of the major risk factors for
the development and spread of antimicrobial resist-
ance [30, 31]. A reason for the lower levels of resist-
ance seen in the layers compared to broilers may be
that the layers in this study were sampled on average
at age 74 weeks, compared to broilers that are usually
aged 6 weeks at time of slaughter. It has been de-
scribed for several animal species that antimicrobial
resistance levels decrease with increasing age [32, 33].
From this point of view, it would be very interesting
to perform longitudinal studies to observe the inter-
action between antimicrobial resistance and the age of
the hens and to monitor the use of antimicrobials
during the rearing of the pullets.
The fact that the samples were analysed in diﬀerent
laboratories in diﬀerent countries may have slightly
inﬂuenced the results, despite the equivalent method-
ology that was used in all four participating countries.
However, the observed diﬀerences in MDR levels be-
tween countries, probably also result from regional
diﬀerences in animal husbandry and antimicrobial
usage and the fact that the distribution of the housing
system of the sampled farms was not the same in
each country. A marked ﬁnding in this respect is the
ceftiofur resistance in E. coli in Belgium. Whereas in
Germany, Italy and Switzerland only very low levels
of ceftiofur resistance were found, in Belgium this re-
sistance was 12.1% in E. coli. Consequentially the
odds to have resistance against ceftiofur were higher
in Belgium compared to the other countries, although
only the diﬀerence with Switzerland was signiﬁcant.
This study result coincides with recent ﬁndings of high
levels of ceftiofur resistance in broilers in Belgium
[28]. It has recently been stated by several authors that
one of the reasons for the increasing levels of ceftiofur
resistance may be the worldwide and systematic use of
ceftiofur in breeding eggs and 1-day-old chicks in the
hatcheries [34, 35]. In Belgium the use of ceftiofur in
poultry has not been licensed for a decade [36] but
might be continued oﬀ-label [28].
Another hypothesis for the increased ceftiofur re-
sistance might be the production on the same farm of
other animal species, in which the use of ceftiofur is
still permitted. This could result in horizontal trans-
mission of resistance genes between bacterial popu-
lations of diﬀerent animal species [37, 38]. However,
the number of mixed-production farms in Belgium did
not signiﬁcantly diﬀer from the situation in Germany
and was even less than in Switzerland. Possibly the
high density of farms in the northern part of Belgium,
where 90% of all animal production is situated,
may enhance contact between the bacterial popula-
tions of diﬀerent ecological systems, for example
surface water, leading to an eﬃcient horizontal spread
of antimicrobial resistance. For humans, it has been
demonstrated that a higher population density en-
hances the development and spread of antimicrobial
resistance [39, 40]. Further eco-epidemiological
studies are needed to elucidate this possibility.
CONCLUSION
The results of this study suggest that the levels of
antimicrobial resistance in indicator bacteria such as
E. coli and E. faecalis in laying-hen ﬂocks are rela-
tively low. The diﬀerences observed between both
indicator bacteria with respect to the potential
1618 S. Van Hoorebeke and others
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268810002700
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 12:54:36, subject to the Cambridge Core terms of use, available at
association between the housing system and MDR
suggest that it is important to not focus on a sole
bacterial species when attempting to assess risk
factors for antimicrobial resistance. It is crucial to
conscientiously monitor the prevalence and evolution
in time of antimicrobial resistance in laying hens,
both during the rearing period and the production
cycle, in order to be able to detect early changes
in antimicrobial resistance and to minimize the
spread of resistant bacteria to humans. Therefore it
is recommended that detailed epidemiological
studies in the ﬁeld and under experimental conditions
on a broader spectrum of indicator bacteria are per-
formed.
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